Weekly Update: New diabetes clinical trial (13 items)

New diabetes clinical trial: The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients Published on: September 29, 2020 at 07:00PM Condition:   Type II Diabetes Interventions:   Drug: PAZ320;   Other: Placebo Sponsor:   Boston Therapeutics Withdrawn https://clinicaltrials.gov/ct2/show/NCT04569214?term=diabetes&sfpd_d=14 September 29, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Rural Dwelling Older Adults With T2DM (Study 2) Published on: September 29, 2020 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Other: Diabetes Empowerment Education Program Sponsor:   Brittany L Smalls Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04568486?term=diabetes&sfpd_d=14 September 29, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Diabetes Communication and Treatment Burden Published on: September 29, 2020 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Multiple Chronic Conditions Interventions:   Other: CI-PVP (context-informed pre-visit planning);   Other: Standard PVP (pre-visit planning) Sponsor:   University of California, Davis Enrolling by invitation https://clinicaltrials.gov/ct2/show/NCT04568382?term=diabetes&sfpd_d=14 September 29, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: The HEADWIND Study - Part 2 Published on: September 30, 2020 at 07:00PM Conditions:   Diabetes;   Diabetes Mellitus, Type 1 Intervention:   Other: Controlled hypoglycaemic state while driving Sponsors:   University Hospital Inselspital, Berne;   ETH Zurich;   University of St.Gallen Recruiting https://clinicaltrials.gov/ct2/show/NCT04569630?term=diabetes&sfpd_d=14 September 30, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Percutaneous CT-guided Cryoablation of the Splanchnic Nerves Published on: September 30, 2020 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Device: CT Guided Splanchnic Cryoablation Sponsors:   Emory University;   Georgia Research Alliance Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04569721?term=diabetes&sfpd_d=14 September 30, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes Published on: September 30, 2020 at 07:00PM Conditions:   Healthy Volunteers;   Diabetes Mellitus, Type 1 Interventions:   Drug: NNC0363-0845;   Drug: Placebo (NNC0363-0845);   Drug: Insulin degludec Sponsor:   Novo Nordisk A/S Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04569994?term=diabetes&sfpd_d=14 September 30, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: MOD Diet in Gestational Diabetes Mellitus Published on: September 30, 2020 at 07:00PM Condition:   Gestational Diabetes Interventions:   Other: MOD Diet;   Other: Standard Care Diet Sponsor:   University of Kansas Medical Center Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04570111?term=diabetes&sfpd_d=14 September 30, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Validation of a Biomathematical Model to Help Identify the Parameters of Flexible Insulin Therapy Published on: October 01, 2020 at 07:00PM Condition:   Type 1 Diabetes Interventions:   Other: Bio-mathematical model;   Other: Without bio-mathematical model Sponsor:   Nantes University Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04572009?term=diabetes&sfpd_d=14 October 01, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Ozempic® (Semaglutide s.c.) in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data Published on: October 01, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Drug: Ozempic®;   Drug: Active Comparator Sponsors:   Novo Nordisk A/S;   Department of Public Health, University of Southern Denmark Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04572165?term=diabetes&sfpd_d=14 October 01, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Changes of Serum Orphanin FQ in Patients With Coronary Heart Disease in Different Courses of Diabetes Mellitus Published on: October 01, 2020 at 07:00PM Condition:   Type2 Diabetes Intervention:   Procedure: Coronary angiography Sponsor:   Second Hospital of Shanxi Medical University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04572802?term=diabetes&sfpd_d=14 October 01, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Health Mindset as a Driver of Efficacy of a Diabetes Prevention Program in the Blackfeet Community Published on: October 01, 2020 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Behavioral: Diabetes Prevention Program;   Behavioral: Health Mindset modified diabetes prevention program Sponsor:   Montana State University Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT04571723?term=diabetes&sfpd_d=14 October 01, 2020 at 03:24PM via ClinicalTrials.gov New diabetes clinical trial: Impact of Digital Therapeutic on Metabolic Parameters Published on: October 02, 2020 at 07:00PM Conditions:   Insulin Resistance;   PreDiabetes;   Type2 Diabetes;   Obesity Interventions:   Device: Vitadio Health;   Behavioral: standard care Sponsors:   Vitadio s.r.o.;   University Hospital Olomouc Recruiting https://clinicaltrials.gov/ct2/show/NCT04573296?term=diabetes&sfpd_d=14 October 02, 2020 at 02:24PM via ClinicalTrials.gov New diabetes clinical trial: Diabetes Outcomes in COVID-19 Pandemic Published on: October 02, 2020 at 07:00PM Conditions:   Diabetes;   Covid19;   Isolation, Social Intervention:   Sponsor:   Services Institute of Medical Sciences, Pakistan Completed https://clinicaltrials.gov/ct2/show/NCT04573335?term=diabetes&sfpd_d=14 October 02, 2020 at 02:24PM via ClinicalTrials.gov